NET PROFIT (x1000 DKK)
EMPLOYEES
Endothelion AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
3
|
0 |
| Earnings before taxes |
-82
|
-88
|
0 |
| EBITDA |
-55
|
-55
|
0 |
| Total assets |
1,001
|
1,258
|
1,494 |
| Current assets |
73
|
268
|
479 |
| Current liabilities |
16
|
17
|
41 |
| Equity capital |
985
|
1,241
|
1,441 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
98.4%
|
98.6%
|
96.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-8.2%
|
-6.8%
|
0% |
| Current ratio |
456.2%
|
1576.5%
|
1168.3% |
| Return on equity (ROE) |
-8.3%
|
-7.1%
|
0% |
| Change turnover |
0
|
0
|
-444 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.